| Date | Time | Source | Headline | Symbol | Company |
| 08/31/2016 | 6:03AM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | AMEX:SYN | Synthetic Biologics Inc |
| 08/26/2016 | 6:05AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:SYN | Synthetic Biologics Inc |
| 08/08/2016 | 6:04AM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | AMEX:SYN | Synthetic Biologics Inc |
| 08/05/2016 | 6:17AM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:SYN | Synthetic Biologics Inc |
| 08/05/2016 | 6:08AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:SYN | Synthetic Biologics Inc |
| 08/03/2016 | 5:04PM | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:SYN | Synthetic Biologics Inc |
| 08/03/2016 | 4:15PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:SYN | Synthetic Biologics Inc |
| 08/03/2016 | 4:01PM | PR Newswire (US) | Synthetic Biologics Reports Second Quarter 2016 Operational Highlights and Financial Results | AMEX:SYN | Synthetic Biologics Inc |
| 08/02/2016 | 6:58AM | PR Newswire (US) | Synthetic Biologics Announces Completion of End of Phase 2 Meeting with FDA for SYN-010, Intended for the Treatment of Irrita... | AMEX:SYN | Synthetic Biologics Inc |
| 07/26/2016 | 6:58AM | PR Newswire (US) | Synthetic Biologics to Report Second Quarter 2016 Operational Highlights and Financial Results on August 3, 2016 | AMEX:SYN | Synthetic Biologics Inc |
| 07/12/2016 | 6:58AM | PR Newswire (US) | Synthetic Biologics Announces Granting of European and U.S. Composition of Matter Patents for Ribaxamase | AMEX:SYN | Synthetic Biologics Inc |
| 07/07/2016 | 6:58AM | PR Newswire (US) | Synthetic Biologics Receives USAN Approval for Generic Name Ribaxamase for Phase 2 Drug Candidate SYN-004 | AMEX:SYN | Synthetic Biologics Inc |
| 07/06/2016 | 4:37PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | AMEX:SYN | Synthetic Biologics Inc |
| 07/06/2016 | 4:36PM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:SYN | Synthetic Biologics Inc |
| 07/06/2016 | 6:58AM | PR Newswire (US) | Synthetic Biologics to Present at the 2nd Annual Cantor Fitzgerald Healthcare Conference | AMEX:SYN | Synthetic Biologics Inc |
| 06/27/2016 | 6:56AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:SYN | Synthetic Biologics Inc |
| 06/02/2016 | 4:32PM | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | AMEX:SYN | Synthetic Biologics Inc |
| 05/23/2016 | 6:50AM | PR Newswire (US) | Synthetic Biologics Announces Detailed Data from Two SYN-010 Phase 2 Clinical Trials for the Treatment of Irritable Bowel Syn... | AMEX:SYN | Synthetic Biologics Inc |
| 05/23/2016 | 6:07AM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:SYN | Synthetic Biologics Inc |
| 05/17/2016 | 6:58AM | PR Newswire (US) | Synthetic Biologics to Host Post-DDW 2016® Conference Call to Recap SYN-010 Phase 2 Clinical Trial Results for the Treatment... | AMEX:SYN | Synthetic Biologics Inc |
| 05/16/2016 | 6:58AM | PR Newswire (US) | Synthetic Biologics Announces Positive Topline Results from Second Phase 2a Clinical Trial of SYN-004 for the Prevention of C... | AMEX:SYN | Synthetic Biologics Inc |
| 05/11/2016 | 6:58AM | PR Newswire (US) | Isaac J. Bright, MD, Joins Synthetic Biologics as Vice President, Corporate Development | AMEX:SYN | Synthetic Biologics Inc |
| 05/09/2016 | 6:58AM | PR Newswire (US) | Synthetic Biologics Appoints Deb Mathews, PharmD, as Vice President, Medical Affairs | AMEX:SYN | Synthetic Biologics Inc |
| 05/05/2016 | 5:41PM | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:SYN | Synthetic Biologics Inc |
| 05/05/2016 | 4:27PM | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:SYN | Synthetic Biologics Inc |
| 05/05/2016 | 4:01PM | PR Newswire (US) | Synthetic Biologics Reports First Quarter 2016 Operational Highlights and Financial Results | AMEX:SYN | Synthetic Biologics Inc |
| 04/26/2016 | 6:58AM | PR Newswire (US) | Synthetic Biologics to Report First Quarter 2016 Operational Highlights and Financial Results on May 5, 2016 | AMEX:SYN | Synthetic Biologics Inc |
| 03/10/2016 | 4:01PM | PR Newswire (US) | Synthetic Biologics Reports 2015 Year End Operational Highlights and Financial Results | AMEX:SYN | Synthetic Biologics Inc |
| 03/09/2016 | 6:58AM | PR Newswire (US) | Synthetic Biologics to Present at the 28th Annual ROTH Conference | AMEX:SYN | Synthetic Biologics Inc |
| 03/03/2016 | 4:01PM | PR Newswire (US) | Synthetic Biologics to Report 2015 Year End Results on March 10, 2016 | AMEX:SYN | Synthetic Biologics Inc |